Charles Stewart Fuchs MD

Gastrointestinal Cancer, Hematologic Oncology

Director, Yale Cancer Center Physician-in-Chief, Smilow Cancer Hospital Richard and Jonathan Sackler Professor of Internal Medicine, Yale School of Medicine

Join to View Full Profile

333 Cedar StYale Cancer CenterNew Haven, CT 06510
Phone+1 203-785-7870
Fax+1 203-785-4116

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1992
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986

Certifications & Licensure

MA State Medical License 1988 - 2027
CT State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2015, 2017
CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2015, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017

Clinical Trials

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 1998 Oct 01
Completed
Phase 3
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer Start of enrollment: 2001 Nov 01
Completed
Phase 1
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer Start of enrollment: 2002 Dec 01
Completed
Phase 3

Publications & Presentations

PubMed

5 citations
Novel metabolomic predictors of incident colorectal cancer in men and women.
Jonathan M Downie, Amit D Joshi, Connor M Geraghty, Brendan J Guercio, Oana A Zeleznik
Journal of the National Cancer Institute. 2025-03-01
18 citations
Remote Monitoring and Data Collection for Decentralized Clinical Trials.
Bobby Daly, Otis W Brawley, Mary K Gospodarowicz, Olufunmilayo I Olopade, Lola Fashoyin-Aje
JAMA Network Open. 2024-04-01
19 citations
Cancer Diagnoses After Recent Weight Loss.
Qiao-Li Wang, Ana Babic, Michael H Rosenthal, Alice A Lee, Yin Zhang
JAMA. 2024-01-23

Journal Articles

Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer
Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature

Lectures

A phase II trial of [fam-] trastuzumab deruxtecan (T-DXd, DS-8201a) in subjects with HER2-positive, unresectable, or metastatic gastric or gastroesophageal junction (G...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

ESMO: Roche Wants Oral SERD to Benefit 'All Comers,' Unveils Phase 3 Breast Cancer DataOctober 18th, 2025
Wisdom, Generosity, and Humor Distinguish Renowned Hematologist, Edward J. Benz Jr., MD, FEL ’79June 12th, 2025
Lifestyle Factors & Cancer Survival Prediction ModelsFebruary 28th, 2022

Grant Support

A Prospective Study Of Diet And Colorectal NeoplasiaNational Cancer Institute2010–2011
Prospective Cohort Collaborative In Pancreatic Cancer Epidemiology &PathogenesisNational Cancer Institute2007–2011
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence And SurvivalNational Cancer Institute2007–2011
Df/Hcc Spore In Gastrointestinal CancerNational Cancer Institute2007–2011
Defining Optimal Doses Of Vitamin D For Chemoprevention In African AmericansNational Cancer Institute2007–2011